Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadra Habibi Moini

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis and Related Disorders|January 24, 2026
Cognitive reserve and its contribution to predicting cognitive performance in multiple sclerosisSadra Habibi Moini, Majid Hamidi, Ali Rezaei, et al.
Clinical Neurology and Neurosurgery|September 25, 2025
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Iranian normative values and correlates of cognitive functionSadra Habibi Moini, Zahra Sarvestani, Majid Hamidi, et al.
CNS Neuroscience & Therapeutics|February 17, 2025
Osteopontin in Alzheimer's Disease: A Double-Edged Sword in Neurodegeneration and Neuroprotection-A Systematic ReviewZahra Azizan, Maryam Bazrgar, Narges Bazgir, et al.
Inflammatory Bowel Diseases|July 2, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumabJoyce Lee, Rachel Porth, Alessandra Saraga, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|January 24, 2026
Cognitive reserve and its contribution to predicting cognitive performance in multiple sclerosisSadra Habibi Moini, Majid Hamidi, Ali Rezaei, et al.
Clinical Neurology and Neurosurgery|September 25, 2025
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Iranian normative values and correlates of cognitive functionSadra Habibi Moini, Zahra Sarvestani, Majid Hamidi, et al.
CNS Neuroscience & Therapeutics|February 17, 2025
Osteopontin in Alzheimer's Disease: A Double-Edged Sword in Neurodegeneration and Neuroprotection-A Systematic ReviewZahra Azizan, Maryam Bazrgar, Narges Bazgir, et al.
Inflammatory Bowel Diseases|July 2, 2026
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumabJoyce Lee, Rachel Porth, Alessandra Saraga, et al.
Pageof 1